Accordingly, CD133 is a CSC marker of human colon cancer and mouse small intestinal tumors; however, in mouse colorectal tumors, CD133 is extensively expressed in goblet cells and cannot be used as a CSC marker, indicating the different regional characteristics of the small intestine and large intestine [61, 68]. This evidence concerns the gene PROM1 and malignant colon neoplasm.